The Middle East & Africa influenza vaccines market is expected to grow from US$ 374.35 million in 2022 to US$ 533.85 million by 2028; it is estimated to grow at a CAGR of 6.1% from 2022 to 2028.
Leading players in the influenza vaccines market have multiple projects on drug delivery and biological pipelines based on proprietary technology. The most advanced candidate population in drug delivery completed 2 Phase I studies. The pipeline also includes a large number of compounds that have completed preclinical evaluation. Pipeline candidates are focused on unlocking the science of the immune system, human genetics, and cutting-edge technologies to develop innovative vaccines. Companies are investing in scientific and technical excellence to develop and introduce new vaccines and specific drugs against infectious diseases, including influenza. Vaccines and viral therapeutic candidates in the pipeline are capable of rapidly and specifically responding to the most pressing health threats in the Middle East & Africa. Thus, strong pipeline candidates for influenza vaccines are the latest trend in the Middle East & Africa influenza vaccines market.
Increase in Government Support to Promote Influenza Vaccination to Bolster Middle East & Africa Influenza Vaccines Market
Leading players in the influenza vaccines market have multiple projects on drug delivery and biological pipelines based on proprietary technology. The most advanced candidate population in drug delivery completed 2 Phase I studies. The pipeline also includes a large number of compounds that have completed preclinical evaluation. Pipeline candidates are focused on unlocking the science of the immune system, human genetics, and cutting-edge technologies to develop innovative vaccines. Companies are investing in scientific and technical excellence to develop and introduce new vaccines and specific drugs against infectious diseases, including influenza. Vaccines and viral therapeutic candidates in the pipeline are capable of rapidly and specifically responding to the most pressing health threats in the Middle East & Africa. Thus, strong pipeline candidates for influenza vaccines are the latest trend in the Middle East & Africa influenza vaccines market.
Market Overview
The Middle East & Africa influenza vaccines market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. In 2022, South Africa was the largest market for influenza vaccines in the region. The market for influenza vaccines in the Middle East & Africa is anticipated to grow at a CAGR of 6.1% during the forecast period. The influenza vaccines market is expected to grow due to the rising population base, increasing cases of influenza, growing research studies across the region, and increasing healthcare facilities.Middle East & Africa Influenza Vaccines Market Segmentation
The Middle East & Africa influenza vaccines market is segmented on the basis of vaccine type, virus type, technology, route of administration, target group, and country.- Based on vaccine type, the Middle East & Africa influenza vaccines market is bifurcated into quadrivalent vaccines and trivalent vaccines. The quadrivalent vaccines segment registered a larger share of the market in 2022.
- Based on virus type, the Middle East & Africa influenza vaccines market is bifurcated into influenza virus type A and influenza virus type B. The influenza virus type A segment held a larger share of the market in 2022.
- Based on technology, the Middle East & Africa influenza vaccines market is divided into egg-based and cell-based. The egg-based segment held a larger share of the market in 2022.
- Based on route of administration, the Middle East & Africa influenza vaccines market is divided into injection and nasal spray. The injection segment held a larger share of the market in 2022.
- Based on target group, the Middle East & Africa influenza vaccines market is segmented into infants, children, adults, and elderly people. The infants segment held the largest share of the market in 2022.
- Based on country, the Middle East & Africa influenza vaccines market is segmented into Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa. Saudi Arabia dominated the market in 2022.
Table of Contents
1. Introduction1.1 Study Scope
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa Influenza Vaccines Market - By Vaccine Type
1.3.2 Middle East & Africa Influenza Vaccines Market - By Virus Type
1.3.3 Middle East & Africa Influenza Vaccines Market - By Technology
1.3.4 Middle East & Africa Influenza Vaccines Market - By Route of Administration
1.3.5 Middle East & Africa Influenza Vaccines Market - By Target Group
1.3.6 Middle East & Africa Influenza Vaccines Market - By Country
2. Middle East & Africa Influenza Vaccines Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Influenza Vaccines Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East and Africa PEST Analysis
4.3 Experts Opinion
5. Middle East & Africa Influenza Vaccines Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Government Support to Promote Influenza Vaccination
5.1.2 Increasing Investment by Top Market Players and Governments
5.2 Market Restraints
5.2.1 High Cost of Vaccine Development
5.3 Market Opportunities
5.3.1 Emerging Economies
5.4 Future Trends
5.4.1 Strong Pipeline Candidates for Influenza Vaccines
5.5 Impact Analysis
6. Influenza Vaccine Market - Middle East & Africa Analysis
6.1 Middle East & Africa Influenza Vaccines Market, By Country - Forecasts And Analysis
6.2 Middle East & Africa Influenza Vaccines Market Revenue Forecasts And Analysis
6.2.1 Middle East & Africa: Influenza Vaccines Market, 2019-2028 (US$ Million)
7. Middle East & Africa Influenza Vaccines Market Analysis and Forecasts To 2028 - By Vaccine Type
7.1 Overview
7.2 Middle East & Africa Influenza Vaccines Market, By Vaccine Type 2022 & 2028 (%)
7.2.1 Middle East & Africa: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
7.3 Quadrivalent Vaccines
7.3.1 Overview
7.3.2 Quadrivalent Vaccines : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Trivalent Vaccines
7.4.1 Overview
7.4.2 Trivalent Vaccines : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
8. Middle East & Africa Influenza Vaccines Market Analysis and Forecasts To 2028 - By Virus Type
8.1 Overview
8.2 Middle East & Africa Influenza Vaccines Market, By Virus Type 2022 & 2028 (%)
8.2.1 Middle East & Africa: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
8.3 Influenza Virus Type A
8.3.1 Overview
8.3.2 Influenza Virus Type A : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Influenza Virus Type B
8.4.1 Overview
8.4.2 Influenza Virus Type B : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
9. Middle East & Africa Influenza Vaccines Market Analysis and Forecasts To 2028 - By Technology
9.1 Overview
9.2 Middle East & Africa Influenza Vaccines Market, By Technology 2022 & 2028 (%)
9.2.1 Middle East & Africa Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
9.3 Egg-based
9.3.1 Overview
9.3.2 Egg-based : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Cell-based
9.4.1 Overview
9.4.2 Cell-Based : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
10. Middle East & Africa Influenza Vaccines Market Analysis and Forecasts To 2028 - By Route of Administration
10.1 Overview
10.2 Middle East & Africa Influenza Vaccines Market, By Route of Administration 2022 & 2028 (%)
10.2.1 Middle East & Africa Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
10.3 Injection
10.3.1 Overview
10.3.2 Injection : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Nasal Spray
10.4.1 Overview
10.4.2 Nasal Spray: Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11. Middle East & Africa Influenza Vaccines Market Analysis and Forecasts To 2028 - By Target Group
11.1 Overview
11.2 Middle East & Africa Influenza Vaccines Market, By Target Group 2022 & 2028 (%)
11.2.1 Middle East & Africa: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
11.3 Infants
11.3.1 Overview
11.3.2 Infants : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11.4 Children
11.4.1 Overview
11.4.2 Children: Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11.5 Adults
11.5.1 Overview
11.5.2 Adults : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11.6 Elderly People
11.6.1 Overview
11.6.2 Elderly People: Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
12. Middle East & Africa Influenza Vaccines Market Analysis and Forecasts To 2028 - Country Analysis
12.1 Middle East & Africa Influenza Vaccine Market Revenue and Forecasts To 2028
12.1.1 Overview
12.1.2 Middle East & Africa: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
12.1.2.1 Saudi Arabia: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.1.1 Saudi Arabia: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.1.2 Saudi Arabia: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
12.1.2.1.3 Saudi Arabia: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
12.1.2.1.4 Saudi Arabia Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
12.1.2.1.5 Saudi Arabia Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
12.1.2.1.6 Saudi Arabia: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
12.1.2.2 UAE: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.2.1 UAE: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.2.2 UAE: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
12.1.2.2.3 UAE: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
12.1.2.2.4 UAE Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
12.1.2.2.5 UAE Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
12.1.2.2.6 UAE: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
12.1.2.3 South Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.3.1 South Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.3.2 South Africa: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
12.1.2.3.3 South Africa: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
12.1.2.3.4 South Africa Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
12.1.2.3.5 South Africa Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
12.1.2.3.6 South Africa: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
12.1.2.4 Rest of Middle East & Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.4.1 Rest of Middle East & Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.4.2 Rest of Middle East & Africa: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
12.1.2.4.3 Rest of Middle East & Africa: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
12.1.2.4.4 Rest of Middle East & Africa: Influenza Vaccine Market, by Technology, 2019-2028 (USD Million)
12.1.2.4.5 Rest of Middle East & Africa: Influenza Vaccine Market, by Route of Administration, 2019-2028 (USD Million)
12.1.2.4.6 Rest of Middle East & Africa: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
13. Middle East & Africa Influenza Vaccine Market -Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Influenza Vaccine Market, 2021-2028
13.3 Inorganic Growth Strategies
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 SEQIRUS
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Sanofi
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 GlaxoSmithKline plc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Mitsubishi Chemical Group Corporation
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Serum Institute of India Pvt. Ltd
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 MYLAN N.V.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 AstraZeneca
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
15. Appendix
15.1 About the Publisher
15.2 Glossary of Terms
Table 1. Middle East & Africa Influenza Vaccines Market- Revenue and Forecast to 2028 (US$ Million)
Table 2. Middle East & Africa Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
Table 3. Middle East & Africa Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
Table 4. Middle East & Africa Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 5. Middle East & Africa Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 6. Middle East & Africa Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 7. Saudi Arabia Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
Table 8. Saudi Arabia Influenza Vaccine Market, by Virus Type- Revenue and Forecast to 2028 (USD Million)
Table 9. Saudi Arabia Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 10. Saudi Arabia Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 11. Saudi Arabia Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 12. UAE Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
Table 13. UAE Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
Table 14. UAE Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 15. UAE Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 16. UAE Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 17. South Africa Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
Table 18. South Africa Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
Table 19. South Africa Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 20. South Africa Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 21. South Africa Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 22. Rest of Middle East & Africa Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
Table 23. Rest of Middle East & Africa Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
Table 24. Rest of Middle East & Africa Influenza Vaccine Market, by Technology- Revenue and Forecast to 2028 (USD Million)
Table 25. Rest of Middle East & Africa Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 26. Rest of Middle East & Africa Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 27. Recent Inorganic Growth Strategies in the Influenza Vaccine Market
Table 28. Recent Organic Growth Strategies in the Influenza Vaccine Market
Table 29. Glossary of Terms, Influenza Vaccines Market
Figure 1. Middle East & Africa Influenza Vaccines Market Segmentation
Figure 2. Middle East & Africa Influenza Vaccines Market Segmentation, by Country
Figure 3. Middle East & Africa Influenza Vaccines Market Overview
Figure 4. Quadrivalent Vaccines Segment Held Largest Share of Product Segment in Middle East & Africa Influenza Vaccines Market
Figure 5. Saudi Arabia Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Middle East and Africa: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Middle East & Africa Influenza Vaccines Market - Revenue Forecasts and Analysis - 2020- 2028
Figure 9. Middle East & Africa Influenza Vaccines Market, by Vaccine Type 2022 & 2028 (%)
Figure 10. Quadrivalent Vaccines: Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. Trivalent Vaccines: Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. Middle East & Africa Influenza Vaccines Market, by Virus Type 2022 & 2028 (%)
Figure 13. Influenza Virus Type A : Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. Influenza Virus Type B: Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. Middle East & Africa Influenza Vaccines Market, by Technology 2022 & 2028 (%)
Figure 16. Egg-based: Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. Cell-Based: Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. Middle East & Africa Influenza Vaccines Market, by Route of Administration 2022 & 2028 (%)
Figure 19. Injection: Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. Nasal Spray: Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. Middle East & Africa Influenza Vaccines Market, by Target Group 2022 & 2028 (%)
Figure 22. Infants : Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. Children: Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. Adults: Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. Elderly People: Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. Middle East & Africa: Influenza Vaccine Market, by Key Country - Revenue (2022) (US$ Million)
Figure 27. Middle East & Africa: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
Figure 28. Saudi Arabia: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
Figure 29. UAE: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
Figure 30. South Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
Figure 31. Rest of Middle East & Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
Figure 32. Growth Strategies in the Influenza Vaccine Market, 2021-2028
Companies Mentioned
- AstraZeneca
- GlaxoSmithKline plc.
- Mitsubishi Chemical Group Corporation
- MYLAN N.V.
- Sanofi
- SEQIRUS
- Serum Institute of India Pvt. Ltd
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 135 |
| Published | January 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 374.35 Million |
| Forecasted Market Value ( USD | $ 533.85 Million |
| Compound Annual Growth Rate | 6.1% |
| Regions Covered | Africa, Middle East |
| No. of Companies Mentioned | 7 |
